• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM5_13.2
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Iritis (1940); Patient Problem/Medical Problem (2688); No Code Available (3191)
Event Date 05/02/2018
Event Type  Injury  
Manufacturer Narrative
This product is not marketed in the us.(b)(4).Device evaluation: lens was returned in liquid, in a specimen cup.Visual inspection found no visible damage to the lens, claim#: (b)(4).
 
Event Description
The reporter indicated that a 13.2mm, vticm5_13.2, -7.00/3.5/164 (sphere/cylinder/axis) implantable collamer lens was implanted into the patient's right eye (od).The lens was removed on the same day, different session (1 hour later).Acute iritis, anterior chamber irrigation, and intraocular injection were reported.Patient related factor was reported as cause of this event.The reporter stated "i believe the cause is patient idiosyncrasy, developed acute iritis (mechanical friction) never seen before.The patient couldn't tolerate the pain (no increase iop) and asked for immediate removal, almost 30 min after implantation."keratoconus was reported as a pre-existing condition.Additional information has been requested but none has been forthcoming.If additional information is received, a supplemental medwatch will be submitted.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Additional information was received: tobradex drops 1x5, nevanac 1mg today, and acetazolamide 250mg 1/2 tab every 6 hours, were prescribed for one week to address the inflammation.Evacuation of viscoelastic is always performed as part of the normal procedure.After explanting the lens the problem resolved, patient is doing fine.(b)(4).No similar complaint type events were reported for units within the same lot.No intraocular injection was used.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
MDR Report Key8070859
MDR Text Key127141417
Report Number2023826-2018-01681
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup,Followup
Report Date 10/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2019
Device Model NumberVTICM5_13.2
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/18/2018
Initial Date Manufacturer Received 10/18/2018
Initial Date FDA Received11/14/2018
Supplement Dates Manufacturer Received11/16/2018
12/12/2018
Supplement Dates FDA Received12/05/2018
12/12/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CARTRIDGE:SFC45, LOT# 1392534; FTP, LOT# 1388835; CARTRIDGE:SFC45, LOT# 1392534; FTP, LOT# 1388835
Patient Outcome(s) Required Intervention;
Patient Age33 YR
-
-